Cross-reactive antibody responses towards viral surface glycoproteins: Translating basic research into novel vaccines and therapeutics The Krammer laboratory studies cross-reactive antibody responses to the surface glycoproteins of antigenically variable RNA viruses. Our main focus is on influenza viruses, but we are also interested in antibody responses to hantaviruses, filoviruses, and other emerging RNA viruses. Work done in the laboratory includes the expression and characterization of viral glycoproteins, generation of glycoprotein-directed monoclonal antibodies, and the characterization of the interaction between antibodies and surface glycoproteins; we are specifically interested in analyzing conserved epitopes and – through detailed studies – aim to elucidate the mechanisms by which these antibodies protect the host from viral infection and disease. The final goal is to translate these findings into novel vaccines and therapeutics.
This book offers readers critical insights into a region in crisis and explores different facets of the crisis from governance to gender to the politics of identity, the challenge of the environment and the enduring impact of demographic variables and technological change.
Gesundheitsminister Rudolf Anschober (Grüne) hat dem Einsatz des vom russischen Präsidenten Wladimir Putin Anfang der Woche präsentierten, weltweit ...
Jetzt gibt es den ersten Coronavirus-Fall im Bundeskanzleramt: Ein Kabinettsmitarbeiter von Regierungschef Sebastian Kurz hat sich im privaten Umfeld ...
Die Beraterin von US-Präsident Donald Trump in der Coronavirus-Krise, die Ärztin Deborah Birx, sieht die USA in einer neuen Phase der Pandemie. „Was wir heute sehen, unterscheidet sich von März und April. Es (das Coronavirus) ist außerordentlich weit verbreitet“, sagte Birx gestern dem Sender CNN.
Bisherige Erkenntnisse zeigen, die Gefahr, sich in einem geschlossenen Räum mit dem Coronavirus zu infizieren, ist im Vergleich zu einer Übertragung ...
UNITED NATIONS — More than 10,000 Islamic State fighters are estimated to remain active in Iraq and Syria two years after the militant group’s defeat, and their attacks have significantly increased this year, the U.N. counter-terrorism chief said Monday.
M. Yagisawa, P. Foster, H. Hanaki, and S. Ōmura. Japanese Journal of Antibiotics, 74 (1):
44-95(2021)Global trends in clinical studies of ivermectin in COVID-19.